Prevention of Maternal to Infant HIV Transmission in India

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 19 Apr 2018

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Nevirapine (Primary)
Indications HIV infections
Focus Adverse reactions; Therapeutic Use
Acronyms SWEN

Most Recent Events

07 Mar 2018 Results (n=107) determining the association of various markers of inflammation with preterm birth in HIV-infected pregnant women presented at the 25th Conference on Retroviruses and Opportunistic Infections
08 Mar 2012 Efficacy analysis according to birth weight presented at the 19th Conference on Retroviruses and Opportunistic Infections.
16 Feb 2010 Combined analysis of the three SWEN trials presented at the 17th Conference on Retroviruses and Opportunistic Infections.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight